|
|
October 31, 2025 |
| Covering
Life Sciences Drugs, Diagnostics,
Devices, Digital Health |
|
|
|
* may need subscription to view |
- Breckenridge: Launch of Everolimus Tablets,
1mg, Generic Version of Zortress
More
- Celldex: Initial Positive Results From Phase
1 Trial of CDX-622 Demonstrating Favorable
Safety and PK Profile and Sustained Mast Cell
Inhibition More
- Daiichi Sankyo: DESTINY-Lung06 Phase 3 Trial
of ENHERTU Initiated as First-Line Therapy in
Patients With HER2 Overexpressing Metastatic
Non-Squamous Non-Small Cell Lung Cancer More
- Manhattan Genomics: Unveils
World-Class Scientific Team to Pioneer New
Era of Genomic Medicine and Eradicate
Inherited Disease
More More
- NeuroKaire: Enters Into R&D
Collaboration With Compass Pathways to
Pioneer Precision Treatments for Depression
More
- Oncotelic Therapeutics: At Forefront of
Effort to Optimize Next-Generation Cancer
Therapies More
- Regeneron: Dupixent (dupilumab) Wins
Prestigious 2025 Prix Galien USA Best
Biotechnology Product Award More
|
|
-
- Get
Full Access to BYTE51 Life Sciences
Intelligence for 50% Off
More
- Helex: Raises $3.5 Million in Seed
Round to Advance Non-Viral Gene Therapies
for Kidney Diseases More
- HHS Approves 340B Rebate Model Plans for
Merck, Bristol Myers and Others More*
More*
- HOOKIPA Pharma: Completion of Sale of HBV
and HIV Assets to Gilead More
- Institute for Life Science Entrepreneurship
(ILSE): Incubator Companies Obtain Multiple
2025 Phase II SBIR and STTR Grants
More
- Intelligent Bio Solutions: Secures 33 New
Customer Accounts in the Fiscal 2026 First
Quarter, Showing Strong Year-Over-Year Growth
and Increasing Total Active Accounts to 480
More
- LSN: Hot Investor Mandates (Updated 10/28) More
- More on Bristol Myers Trying to Temper
Anxiety Over Upcoming Cobenfy Readout,
Unveiling Suite of PD-1xVEGF Bispecific Trials
More*
More*
More
More
- More on Merck CEO Touting Winrevair Launch,
Saying He’s Looking for Deals ‘With Urgency’ More*
More*
More*
More
- More on Novo Nordisk Launching
Bidding War With Pfizer, Offering Up to $9
Billion for Metsera More*
More*
More*
More*
|
|
|
- BioPharmGuy News: Bidding War, Lizard
Invasion, Apr-2020, Huge Whoop
More
- Decoded Brain Circuits Show How Mice
Stabilize Memories During Learning More
- Event Recap: "Biotech is Dead: Long
Live Biotech!" More
- Researchers Release the World’s First
Head-to-Toe Cellular Atlas of the Mosquito More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
|
|
|
|
Feature your company |
|
Apply to have your company
showcased by Big4Bio. |
|
|
|
|
|
|
| Elevating
Executive Presence: A Blueprint
for Life Sciences and Biotech
Leaders |
|
Learn More
→ |
|
|
- CEO's Perspective: Big Moves Come with Big
Responsibilities More
- CEO's Perspective: The High Cost of Job
Hopping More
- 8 Companies Hiring Now in New York More
- ICYMI: The Power of Peer Learning: Why Even
Top Biotech Leaders Need Mentorship More
- OrbiMed-Backed Biotech Quickly Changes CEOs;
Adaptimmune Co-Founder to Lead Evaxion More*
- What’s Next in Precision Medicine:
Leadership Challenges and Opportunities More
|
|
|
Event
Center
|
Note:
Events may be in any Big4Bio region or
virtual |
|
- Pantheon 2025
Nov 6
- BIO-Europe
2025 Nov
11-12
- Copay,
Reimbursement and Access Congress (Save 10%
with VIP code: 25B4B10) Nov
18-20
- Pharma/Biotech
Gross-To-Net Summit (Save 10% with VIP code:
25B4B10) Nov
18-20
- Patient
Support Services Congress (Save 10% with VIP
code: 25B4B10) Nov
20-21
- Compounding
Pharmacy Compliance (Save 10% with VIP code:
25B4B10) Dec
9-10
- Trade
and Channel Strategies (Save 10% with VIP
code: 25B4B10) Dec
9-11
- Advancing
Drug Development Forum Dec
11
|
SEE FULL
EVENT SCHEDULE AT THE BIOCALENDAR
|
|
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|